Effectiveness of risk minimization measures for the use of cilostazol in United Kingdom, Spain, Sweden, and Germany

PURPOSE: The purpose of the study is to evaluate the effectiveness of risk minimization measures—labeling changes and communication to health care professionals—recommended by the European Medicines Agency for use of cilostazol for the treatment of intermittent claudication in Europe. METHODS: Obser...

Descripción completa

Detalles Bibliográficos
Autores principales: Castellsague, Jordi, Poblador‐Plou, Beatriz, Giner‐Soriano, Maria, Linder, Marie, Scholle, Oliver, Calingaert, Brian, Bui, Christine, Arana, Alejandro, Laguna, Clara, Gonzalez‐Rubio, Francisca, Roso‐Llorach, Albert, Prados‐Torres, Alexandra, Perez‐Gutthann, Susana
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2018
Materias:
Original Reports
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6175151/
https://www.ncbi.nlm.nih.gov/pubmed/30043552
http://dx.doi.org/10.1002/pds.4584

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6175151/
https://www.ncbi.nlm.nih.gov/pubmed/30043552
http://dx.doi.org/10.1002/pds.4584

Ejemplares similares